STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 74 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $183,000 | -71.4% | 37,627 | -37.4% | 0.00% | – |
| Q4 2019 | $639,000 | -61.8% | 60,092 | -62.6% | 0.00% | -100.0% |
| Q3 2019 | $1,673,000 | +39.1% | 160,654 | +104.7% | 0.00% | – |
| Q2 2019 | $1,203,000 | +103.2% | 78,500 | +70.2% | 0.00% | – |
| Q1 2019 | $592,000 | -41.6% | 46,126 | -56.7% | 0.00% | – |
| Q4 2018 | $1,013,000 | +82.5% | 106,614 | +218.6% | 0.00% | – |
| Q3 2018 | $555,000 | +44.2% | 33,459 | +39.7% | 0.00% | – |
| Q2 2018 | $385,000 | -51.5% | 23,953 | -53.8% | 0.00% | – |
| Q1 2018 | $793,000 | +338.1% | 51,877 | +348.3% | 0.00% | – |
| Q4 2017 | $181,000 | +69.2% | 11,573 | +19.8% | 0.00% | – |
| Q3 2017 | $107,000 | -54.3% | 9,661 | -61.9% | 0.00% | – |
| Q2 2017 | $234,000 | +1.7% | 25,359 | -5.9% | 0.00% | – |
| Q1 2017 | $230,000 | +82.5% | 26,945 | +130.0% | 0.00% | – |
| Q4 2016 | $126,000 | +40.0% | 11,713 | +40.9% | 0.00% | – |
| Q3 2016 | $90,000 | +76.5% | 8,311 | +10.8% | 0.00% | – |
| Q2 2016 | $51,000 | +45.7% | 7,500 | 0.0% | 0.00% | – |
| Q1 2016 | $35,000 | -20.5% | 7,500 | +6.9% | 0.00% | – |
| Q4 2015 | $44,000 | -18.5% | 7,014 | +14.0% | 0.00% | – |
| Q3 2015 | $54,000 | -45.5% | 6,150 | -27.2% | 0.00% | – |
| Q2 2015 | $99,000 | +106.2% | 8,450 | +152.2% | 0.00% | – |
| Q1 2015 | $48,000 | -15.8% | 3,350 | 0.0% | 0.00% | – |
| Q4 2014 | $57,000 | – | 3,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|